根治性前列腺切除术后的挽救性放疗:尿失禁、毒性和治疗结局的长期结果
该回顾性队列分析纳入1998至2012年在本机构接受挽救性放疗(SRT,3D-CRT)的244例根治性前列腺切除术后生化复发前列腺癌患者,中位随访50个月。SRT后急性与晚期新发尿失禁(≥1级)分别为6.1%和17.6%,晚期≥2级泌尿生殖毒性和胃肠道毒性分别为29.9%和21.3%,5年生化无进展生存率为47.6%。作者结论认为SRT可获得良好的长期生化控制,但毒性和尿失禁发生率较高。
要点
- 244例根治性前列腺切除术后生化复发患者接受挽救性放疗,中位随访50个月。
- SRT后急性与晚期新发尿失禁(≥1级)分别为6.1%和17.6%。
- 晚期≥2级泌尿生殖毒性和胃肠道毒性分别为29.9%和21.3%,5年生化无进展生存率为47.6%。
核心结论
- 作者所在机构的SRT经验显示该治疗可获得良好的长期生化控制,但毒性和尿失禁发生率较高。
研究设计与样本
- 回顾性队列分析,纳入1998年至2012年在本机构接受挽救性放疗(3D-CRT)的根治性前列腺切除术后生化复发前列腺癌患者244例。
- 主要终点为尿失禁发生率,次要终点包括急性和晚期≥2级泌尿生殖(GU)与胃肠道(GI)毒性、生化无进展生存(bPFS)、无远处转移生存(DMFS)、疾病特异性生存(DSS)和总生存(OS)。
主要发现
- SRT后中位随访50个月(范围4-187个月)。
- SRT开始前69.7%的患者尿液控制良好。
- SRT后急性期和晚期分别有6.1%和17.6%的患者出现新发尿失禁主诉(≥1级)。
- 急性≥2级GU毒性和GI毒性分别为19.2%和17.6%;晚期≥2级GU毒性为29.9%,GI毒性为21.3%。
- 5年bPFS、OS、DSS和DMFS率分别为47.6%、91.8%、98.8%和80.5%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: For patients with local recurrent disease after radical prostatectomy (35-54%) salvage radiotherapy (SRT) is the treatment of choice. In the post prostatectomy setting, SRT may impose risk at increased toxicity. As data on long-term toxicity, especially on urinary incontinence, are scarce, we report on the long-term treatment outcomes, toxicity and urinary incontinence rates after SRT. MATERIALS AND METHODS: Patients with biochemically recurrent prostate cancer after radical prostatectomy, who were treated with SRT (3D-CRT) at our institution between 1998 and 2012, were included in this retrospective cohort analysis. Primary endpoint was urinary incontinence rate. Secondary endpoints were acute and late grade ≥2 genitourinary (GU) and gastrointestinal (GI) toxicity rates, biochemical progression-free survival (bPFS), distant metastasis-free survival (DMFS), disease specific survival (DSS), and overall survival (OS). RESULTS: 244 patients were included. Median follow-up after SRT was 50 months (range: 4-187 months). Before start of SRT 69.7% of patients were continent for urine. After SRT de novo urinary incontinence complaints (grade ≥ 1) occurred in the respective acute and late phase in 6.1% and 17.6% of patients. Respective acute grade ≥2 GU and GI toxicity was 19.2% and 17.6%. Late grade ≥2 toxicity for GU was 29.9% and for GI was 21.3%, respectively. The respective 5-year bPFS, OS, DSS and DMFS rates were 47.6%, 91.8%, 98.8% and 80.5%. CONCLUSIONS: Experience at our institution with SRT demonstrates that this results in good long-term biochemical control. However, toxicity and urinary incontinence rates were high.
引用
- van Dessel LF, Reuvers SHM, Bangma CH, et al. Salvage radiotherapy after radical prostatectomy: Long-term results of urinary incontinence, toxicity and treatment outcomes. Clin Transl Radiat Oncol. 2018. PMID: 30014044. doi:10.1016/j.ctro.2018.05.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。